Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the “Global Continuous Glucose Monitoring (CGM) Sensors Market- by Products (Non-invasive Sensing and Minimally Invasive Sensing), Sensing Technology (Enzyme Electrode, Optical Fluorescence and Others), End-Users (Hospitals and Home care, Specialty Clinics, Ambulatory Settings and Others), Patient Population (Children and Teenagers and Adults), Sensor Sites (Abdomen, Upper Arm (implanted), Back of Upper Arms and Other (Abdomen and Buttocks)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by Insightace Analytics, the global Continuous Glucose Monitoring (CGM) Sensors Market Size is valued at USD 7.6 Billion in 2024 and is predicted to reach USD 19.9 Billion by the year 2034 at a 10.2% CAGR during the forecast period for 2025-2034.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1181
Diabetes is a complicated, long-term illness requiring constant medical treatment, varied risk-reduction strategies, and glucose management. Diabetes is a severe health problem among the elderly; around one-quarter of people over 65 have diabetes, which is expected to skyrocket in the next decades. Continuous glucose monitoring devices aid in the detection of high blood glucose levels. CGM systems are the most effective method of controlling and managing diabetes.
A rise in Type 1 and Type 2 diabetes incidence, greater sensor device adoption, technological developments in diabetic devices, and increased funding for diabetes are all expected to drive the market. A continuous glucose monitoring device can help patients manage and control their illness. Therefore, a continuous glucose monitoring device can assist those with diabetes types 1 and 2 receive the necessary care. Wearable medical devices are predicted to be widely used during the projection period, and advancements in wireless technology for CGM sensors are anticipated to open up several promising opportunities. In the upcoming years, it is anticipated that the miniaturization of electrochemical-based implanted CGM systems will present profitable growth prospects.
North America is anticipated to majorly contribute to the Continuous Glucose Monitoring (CGM) Sensors market over the forecast years because of the healthcare industry’s early adoption of emerging technologies. The rapid development in product innovation and the expanding demand for these CGM systems in diabetes treatment are also driving global product demand.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1181
Request for ToC/Proposal:
Major market players operating in the Continuous Glucose Monitoring (CGM) Sensors market include
Medtronics, Abbott, Senseonics, WaveForm Technologies, Inc., Advanced Biosensors-Ohio LLC, Arkal Medical, Inc., Ascensia Diabetes Care Holdings AG, Azurite Technologies, Inc., Biorasis Inc, Biovotion AG, CALISTO MEDICAL, INC., CGM3 Ltd, ConvaTec Group Plc, Cyber Medical Ltd, Debiotech SA, DexCom Inc, DirectSens GmbH, Echo Therapeutics Inc, Ecole Polytechnique Federale de Lausanne, eLutions Integrated Systems, Inc., EyeSense GmbH, Flowsion A/S, Gili Medical Ltd, Globe Medical Tech Inc, GlucoLight Corporation, Glucometrix AG, Glucosense Diagnostics Ltd, GlucoSet AS, Glucovation Inc, GluMetrics Inc, Glusense Ltd, GlySens Inc, Glysure Ltd, G-Sense Ltd., iGlyko, Inc., Indigo Diabetes NV, Innovosens AB, Insulet Corp, Integrated Medical Sensors, Integrity Applications Ltd, Invivosense ASA, I-Sens Inc, iSense Corporation, Keratin Biosciences Inc, Kiffik Biomedical inc., LEMM Technologies, LLC, Mellitor Ltd, Metronom Health Inc, mobiLIFE, Nemaura Medical Inc, Newton Photonics Inc, Orsus Medical Ltd, PKvitality, PositiveID Corp, Prediktor Medical AS, Profusa Inc, Purdue University, San Meditech (Huzhou) Co., Ltd., Senseonics Holdings Inc, SensiVida Medical Technologies, Inc., Senzime AB, Singapore Biomicro Pte Ltd, Socrates Health Solutions, Inc., Tenax Therapeutics Inc, VeriTeQ Corporation, Vytrace, Inc., and Other Prominent Players.
Recent collaborations and agreements in the market:
- In May 2021, Medtronic achieved CE clearance for prolonged use of its InPen smart insulin pen for multiple daily injections (MDI) and its Guardian 4 sensor for enhanced diabetes management.
- In November 2020, according to a recent announcement from Abbott, women in India who have gestational diabetes (diabetes during pregnancy) and adults and children (over the age of four) who have diabetes now have access to the FreeStyle Libre system, continuous glucose monitoring (CGM) technology, allowing them to check their blood sugar levels at any time.
Get Specific Chapter/Information From The Report:@
https://www.insightaceanalytic.com/customisation/1181
Market Segments
Global Continuous Glucose Monitoring (CGM) Sensors Market, by Products, 2022-2028 (Value US$ Mn)
- Non-invasive Sensing
- Minimally Invasive Sensing
Global Continuous Glucose Monitoring (CGM) Sensors Market, by Sensing Technology, 2022-2028 (Value US$ Mn)
- Enzyme Electrode
- Optical Fluorescence
- Others
Global Continuous Glucose Monitoring (CGM) Sensors Market, by End-Users, 2022-2028 (Value US$ Mn)
- Hospitals and Home care
- Specialty Clinics
- Ambulatory Settings
- Others
Global Continuous Glucose Monitoring (CGM) Sensors Market, by Patient Population, 2022-2028 (Value US$ Mn)
- Children and Teenagers
- Adults
Global Continuous Glucose Monitoring (CGM) Sensors Market, by Sensor Sites, 2022-2028 (Value US$ Mn)
- Abdomen
- Upper Arm (implanted)
- Back of Upper Arm
- Other (Abdomen and Buttocks)
Global Continuous Glucose Monitoring (CGM) Sensors Market, by Region, 2022-2028 (Value US$ Mn)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
- S.
- Canada
Europe Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Continuous Glucose Monitoring (CGM) Sensors Market, by Country, 2022-2028 (Value US$ Mn)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Get More Information :
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
